These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12134238)

  • 21. HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease.
    Cianci R; De Luca A; Cammarota G; Cauda R; Pandolfi F
    Eur Rev Med Pharmacol Sci; 2008; 12(1):67-9. PubMed ID: 18401975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
    De Rossi A; Walker AS; De Forni D; Klein N; Gibb DM;
    Antivir Ther; 2005; 10(1):63-71. PubMed ID: 15751764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Kolte L; Dreves AM; Ersbøll AK; Strandberg C; Jeppesen DL; Nielsen JO; Ryder LP; Nielsen SD
    J Infect Dis; 2002 Jun; 185(11):1578-85. PubMed ID: 12023763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.
    Gibellini D; Borderi M; De Crignis E; Cicola R; Cimatti L; Vitone F; Chiodo F; Re MC
    J Infect; 2008 Mar; 56(3):219-25. PubMed ID: 18276011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
    AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological and virological failure after antiretroviral therapy is associated with enhanced peripheral and thymic pathogenicity.
    Solomon A; Cameron PU; Bailey M; Dunne AL; Crowe SM; Hoy JF; Lewin SR
    J Infect Dis; 2003 Jun; 187(12):1915-23. PubMed ID: 12792868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparameter evaluation of human thymic function: interpretations and caveats.
    Harris JM; Hazenberg MD; Poulin JF; Higuera-Alhino D; Schmidt D; Gotway M; McCune JM
    Clin Immunol; 2005 May; 115(2):138-46. PubMed ID: 15885636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy.
    Franco JM; Rubio A; Martínez-Moya M; Leal M; Merchante E; Sánchez-Quijano A; Lissen E
    Blood; 2002 May; 99(10):3702-6. PubMed ID: 11986226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).
    Ruiz-Mateos E; Rubio A; Vallejo A; De la Rosa R; Sanchez-Quijano A; Lissen E; Leal M
    Clin Exp Immunol; 2004 Jun; 136(3):501-6. PubMed ID: 15147352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.
    Ruiz-Mateos E; de la Rosa R; Franco JM; Martinez-Moya M; Rubio A; Soriano N; Sanchez-Quijano A; Lissen E; Leal M
    AIDS; 2003 May; 17(7):947-54. PubMed ID: 12700443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation.
    Hazenberg MD; Verschuren MC; Hamann D; Miedema F; van Dongen JJ
    J Mol Med (Berl); 2001 Nov; 79(11):631-40. PubMed ID: 11715066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing thymopoiesis in patients with common variable immunodeficiency as measured by T-cell receptor excision circles.
    De Vera MJ; Al-Harthi L; Gewurz AT
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):478-84. PubMed ID: 15562888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Genebat M; Ruiz-Mateos E; Leal M; Pacheco YM
    Clin Infect Dis; 2017 Jan; 64(2):152-158. PubMed ID: 27986677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.
    Saitoh A; Singh KK; Sandall S; Powell CA; Fenton T; Fletcher CV; Hsia K; Spector SA
    J Allergy Clin Immunol; 2006 Apr; 117(4):909-15. PubMed ID: 16630951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.